Bioinspired nanoparticles deliver gene editing to lower 'bad' cholesterol

Дата публикации: 25-08-2026 18:00:12

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Tianjin Medical University General Hospital have developed a bioinspired lipid nanoparticle (LNP) that can deliver gene-editing machinery to the liver and reduce low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol. The nanoparticles reduced LDL and total cholesterol by more than 20% after two doses, while showing fewer signs of inflammation and toxicity than comparator formulations. The findings were published in the Journal of Controlled Release.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New lipid nanoparticle delivers capped circular RNA for longer-lasting gene expression	0	11.99	19-08-2026
2	New pill cuts “bad” cholesterol by 60% in major trial	0	8.9	21-03-2026
3	La terapia génica que promete controlar el colesterol con una sola dosis	0	9.88	03-09-2026
4	Acid-resistant nanocage shows promise for targeted gastric cancer therapy	0	9.81	20-07-2026
5	Nanoparticles induce neuroregeneration in Alzheimer's disease models	0	6.87	26-08-2026
6	Cholesterol-linked drug boosts gene-targeting potency in early findings	0	17.58	12-10-2026
7	Созданы магнитные наночастицы для управления работой генов	0	0	05-05-2025
8	CRISPR roadblocks: Scientists identify genes blocking gene therapy success	0	7.78	13-08-2026
9	Helical nanoparticles trigger cancer alarms and deliver gene therapy	0	5.41	28-07-2026
10	Small-molecule switches put therapeutic CRISPR editing under on-demand control in living tissues	5	7	03-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.25. Источник: phys.org.